News | Pacemakers | December 12, 2022

Global Pacemakers Market Set to Grow at 5.4% CAGR Over Next 3 Years

The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between 2022 and 2025, driven by increasing population at a risk of cardiovascular diseases.

Getty Images


December 12, 2022 —  The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between 2022 and 2025, driven by increasing population at a risk of cardiovascular diseases. Among pacemakers, dual chamber pacemakers are the fastest growing subsegment, growing at a rate of 5.6%, reveals GlobalData, a leading data and analytics company.

GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025. That brings the price of one pacemaker from $4730 to $4260, a reduction of almost $500 in just three years.

Cynthia Stinchcombe, Medical Devices Analyst at GlobalData, comments: “The continuing demand for pacemakers in emerging countries can be attributed to affordable prices, easy availability in healthcare centers and favorable physician perception. The need for a large number of devices to cater for the substantial patient population in countries such as India and China will neutralize the loss due to reduced average prices and help to sustain the growth of revenues from this market.”

Advancing technology will propel the use of pacemakers with future improvements addressing the current limitations of the system: invasiveness. Aadvanced technology will make the pacemakers smaller in size and easier to implant.

Leadless pacemaker implantations have been found to be less invasive, improved quality of life, and reduced post-operative complications compared to traditional pacemakers.

Stinchcombe concludes: “In 2021, Medtronic was the only manufacturer to manufacture leadless pacemakers in this market and continues to be remain the sole manufacturer into 2022. However, competitors such as Abbott Medical currently have leadless pacemakers undergoing clinical trial and are set to give tough competition to Medtronic.”

For more information: www.globaldata.com


Related Content

News | Pacemakers

June 9, 2022 — Holes help make sponges and English muffins useful (and, in the case of the latter, delicious). Without ...

Home June 09, 2022
Home
News | Pacemakers

April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber ...

Home April 05, 2022
Home
News | Pacemakers
February 16, 2022 – A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be ...
Home February 16, 2022
Home
News | Pacemakers

August 9, 2021 — Boston Scientific is recalling INGENIO family of pacemakers and CRT-Ps due to the risk of incorrect ...

Home August 09, 2021
Home
News | Pacemakers

June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...

Home June 16, 2020
Home
Videos | Pacemakers

This video illustrates how the Micra AV leadless pacemaker is delivered via catheter and enables atrioventricular (AV) ...

Home February 13, 2020
Home
News | Pacemakers

February 13, 2020 — The U.S. Food and Drug Administration (FDA) has approval of Micra AV, the world’s smallest pacemaker ...

Home February 13, 2020
Home
News | Pacemakers

(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020 - FDA ...

Home November 15, 2019
Home
News | Pacemakers

November 13, 2019 — Texas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the ...

Home November 13, 2019
Home
News | Pacemakers | Dave Fornell, Editor

May 7, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers ...

Home May 07, 2019
Home
Subscribe Now